期刊文献+

FTY720对大鼠心脏移植急性排斥反应的影响 被引量:1

Effect of FTY720 on acute rejection after cardiac transplantation in rats
下载PDF
导出
摘要 目的观察FTY720对大鼠心脏移植急性排斥反应(AR)的影响并探讨其相关机制。方法利用Cuff技术建立颈部异位心脏移植模型,受体大鼠随机分为对照组和FTY720组,每组12只。FTY720组自术前3 d至术后11 d管饲FTY720(3 mg·kg^(-1)),对照组管饲等量生理盐水。2组均于术后第5天随机选6只动物抽取外周血后留取标本,其余6只观察存活期。苏木素-伊红染色光镜下观察排斥反应级别;流式细胞仪检测外周血CD4^+T淋巴细胞和CD8^+T淋巴细胞。结果FTY720组心脏移植物平均存活时间长于对照组,排斥反应级别低于对照组,CD4^+T淋巴细胞和CD8^+T淋巴细胞阳性率低于对照组,差别均有统计学意义(P<0.05)。结论FTY720能明显减轻大鼠心脏移植AR。 Objective To study the effect of FTY720 on acute rejection(AR) after cardiac transplantation and investigate the coherent mechanisms.Methods The model of cervical heterotopic cardiac transplantation was established by cuff technique. The recipients were randomly divided into control group and FTY720 group,12 in each group.The FTY720 group were administered with FTY720 orally at a dosage of 3 mg·kg^(-1) for 3 days before grafting to 11 days after grafting;The control group were administered with physiologic saline in the same way.Six recipients in each group were randomly chosen for collecting blood samples on the 5th day after oparation,the other six recipients reserved to observe the survival duration in each group.Cardiac allograft rejection grades were observed under light microscope.CD4~+ T-lymphocytes and CD8~+ T-lymphocyte were detected by flow cytometry.Results The survival durations of the grafts were significantly longer and the rejection degress were significantly lower in FTY720 group than thoes in control group(P0.05).The positive rates of CD4~+ T-lymphocyte and CD8~+ T-lymphocyte were significantly lower in FTY720 group than those in control group(P0.05).Conclusion The FTY720 can reduce the acute rejection in rat after heart transplantation.
出处 《新乡医学院学报》 CAS 2010年第1期33-35,共3页 Journal of Xinxiang Medical University
关键词 FTY720 急性排斥反应 心脏移植 T-淋巴细胞 FTY720 acute rejection cardiac transplantation T-lymphocyte
  • 相关文献

参考文献14

  • 1王春生.中国大陆心脏移植的现状与进展[J].继续医学教育,2007,21(11):6-9. 被引量:12
  • 2韩玲,肖燕燕.心脏移植及心肺联合移植[J].实用儿科临床杂志,2008,23(1):9-16. 被引量:5
  • 3苏刚,孙宗全,董念国,陈家军,刘超,高开柱.“袖套”法小鼠颈部异位心脏移植模型的改进[J].新乡医学院学报,2006,23(5):435-437. 被引量:7
  • 4Stewart S,Winters G L, Fishbein M C,et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection[ J]. J Heart Lung Transplant ,2005,24 (11) : 1710-1720.
  • 5郭春艳,韩波.细胞毒性T淋巴细胞抗病毒感染作用机制的研究进展[J].中华儿科杂志,2007,45(2):155-157. 被引量:3
  • 6Yanagawa Y, Hoshino Y, Chiba K ,et al. The significance of timing of FTY720 administration on the immunosuppressive effect to prolong rat skin allograft survival [ J ]. Int J Immunopharmacol, 2000,22(8) : 597- 602.
  • 7Zhang L,Zhu T,Sun E W,et al. Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft[ J]. Transplant Proc,2003,35 ( 1 ) ,567-568.
  • 8Wang M E, Tejpal N, Qu X, et al. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus [ J ]. Transplantation, 1998,65 ( 7 ) : 899-905.
  • 9Mitsusada M, Suzuki S, Kobayashi E,et al. Prevention of graft rejection and graft-versus-host reaction by a novel immunosuppressant, FTY720, in rat small bowel transplantation [ J ]. Transpl Int, 1997,10(5) : 343-349.
  • 10Chiba K, Yanagawa Y, Masubuchi Y, et al. FTY720, a novel im munosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selebtively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing [ J ]. J Immunol, 1998,160 (10) : 5037-5044.

二级参考文献58

  • 1叶子峥,李幼平.袖套法小鼠颈部心脏移植模型的改进[J].华西医学,2005,20(1):83-84. 被引量:3
  • 2Yopp A C,Ledgerwood L G,Ochando J C et al.Sphingosine 1-phosphate receptor modulators:a new class of immunosuppressants[J].Clin Transplant,2006;20(6):788-795.
  • 3Anada Y,Igarashi Y,Kihara A.The immunomodulator FTY720 is phosphorylated and released from platelets[J].Eur J Pharmacol,2007;568(1-3):106-111.
  • 4Capra V,Veltri A,Foglia C et al.Mutational analysis of the highly conserved ERY motif of the thromboxane A2 receptor:alternative role in G protein-coupled receptor signaling[J].Mol Pharmacol,2004;66(4):880-889.
  • 5Colvin R A,Campanella G S,Sun J et al.Intracellular domains of CXCR3 that mediate CXCL9,CXCL10,and CXCL11 function[J].J Biol Chem,2004;279(29):30219-30227.
  • 6Brinkmann V.Sphingosine 1-phosphate receptors in health and disease:Mechanistic insights from gene deletion studies and reverse pharmacology[J].Pharmacol Ther,2007;115(1):84-105.
  • 7Albert R,Hinterding K,Brinkmann V et al.Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer.Identification,chemical proof,and biological characterization of the biologically active species and its enantiomer[J].J Med Chem,2005;48(16);5373-5377.
  • 8Zemann B,Kinzel B,Muller M et al.Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720[J].Blood,2006;107(4):1454-1458.
  • 9Graler M H,Goetzl E J.The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors[J].FASEB J,2004;18(3):551-553.
  • 10deLevalS.先天性心脏病外科学[M].北京:人民卫生出版社,1996.357.

共引文献26

同被引文献15

  • 1安云庆,姚智.医学免疫学[M].2版,北京:北京大学医学出版社,2009:71.
  • 2McLaren BK, Venkatesh PK, Misra P, et al. Increased expression of p53 protein correlates with the extent of myocyte damage in cardiac aUograft rejection [ J ]. Congest Heart Fail,2008,14 ( 6 ) :293 - 297.
  • 3Lee B, Oh CK, Kim MS, et al. Cytokine gene expression in peripher- al blood mononuclear ceils during acute renal allograft rejection [ J ]. Transplant Prec ,2012,44 ( 1 ) :236 - 240.
  • 4Zeglen S, Laszewska A, Wojarski J, et al. Lymphocyte subtypes CD3^ + , CD19 ^+ , CD16 + CD56 ^+ , CD4^ + , CD8 ^+ , and CD3 ^+ HLA- DR + in peripheral blood obtained from patients after thoracic organ transplantation[ J]. Transplant Proc ,2011,43 ( 8 ) :3055 - 3057.
  • 5Sindhi R, Ashokkumar C, Higgs BW. Cellular alloresponses for re- jection-risk assessment after pediatric transplantation[ J ]. Curt Opin Organ Transplant,2011,16(5) :515 -521.
  • 6Vallotton L, Hadaya K, Venetz JP, et al. Monitoring of CD4^+ CD25highIL-7Rcthigh activated T cells in kidney transplant recipi- ents [ J ]. Clin J Am Soc Nephrol, 2011,6 ( 8 ) : 2025 - 2033.
  • 7Josephson MA. Monitoring and managing graft health in the kidney transplant recipient[ J]. Clin J Am Soc Nephro1,2011,6 (7) : 1774 - 1780.
  • 8TLee B,Oh CK,Kim MS,et al. Cytokine gene expression in periph- eral blood mononuclear cells during acute renal allograft rejection [J]. Transplant Proc,2012,44(1 ) :236- 240.
  • 9Park JH, Lee JH, Joo D J, et al. Effect of sevoflurane on grafted kid- ney function in renal transplantation [ J ]. Korean J Anesthesiol, 2012,62(6) :529-535.
  • 10From AM, Maleszewski JJ, Rihal CS. Current status of endomyocardi- al biopsy[J]. Mayo Clin Proc,2011,86( 11 ) :1095 - 1102.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部